Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Tongling Jieya Biologic Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥28.00 |
52 Week High | CN¥40.60 |
52 Week Low | CN¥23.14 |
Beta | 0.54 |
1 Month Change | -4.44% |
3 Month Change | -18.93% |
1 Year Change | -29.26% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -66.13% |
Recent News & Updates
Recent updates
Shareholder Returns
301108 | CN Personal Products | CN Market | |
---|---|---|---|
7D | -5.6% | -4.7% | -4.9% |
1Y | -29.3% | -29.6% | -16.6% |
Return vs Industry: 301108 matched the CN Personal Products industry which returned -29.6% over the past year.
Return vs Market: 301108 underperformed the CN Market which returned -16.6% over the past year.
Price Volatility
301108 volatility | |
---|---|
301108 Average Weekly Movement | 5.0% |
Personal Products Industry Average Movement | 6.5% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 11.5% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 301108's share price has been volatile over the past 3 months.
Volatility Over Time: 301108's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 620 | Yingchuan Cai | https://www.babywipes.com.cn |
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sales of wet wipe products in China. It offers baby, adult functional, antibacterial and disinfection, household clearing, medical care, and pet cleaning wipes.
Tongling Jieya Biologic Technology Co., Ltd. Fundamentals Summary
301108 fundamental statistics | |
---|---|
Market cap | CN¥2.25b |
Earnings (TTM) | CN¥116.91m |
Revenue (TTM) | CN¥586.54m |
19.4x
P/E Ratio3.9x
P/S RatioIs 301108 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301108 income statement (TTM) | |
---|---|
Revenue | CN¥586.54m |
Cost of Revenue | CN¥402.54m |
Gross Profit | CN¥183.99m |
Other Expenses | CN¥67.08m |
Earnings | CN¥116.91m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Apr 20, 2024
Earnings per share (EPS) | 1.44 |
Gross Margin | 31.37% |
Net Profit Margin | 19.93% |
Debt/Equity Ratio | 0.3% |
How did 301108 perform over the long term?
See historical performance and comparison